Related Experiment Video
Updated: Aug 4, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Gluten antibodies in patients with multiple sclerosis
Human Nutrition. Applied Nutrition
|April 1, 1984
Summary
This study found no evidence that gluten antibodies are common in multiple sclerosis (MS) patients. Therefore, a gluten-free diet is not supported for managing MS based on these findings.
Area of Science:
- Immunology
- Neurology
- Dietary Science
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- Dietary interventions, such as gluten-free diets, are sometimes explored for managing MS.
- The role of gluten antibodies in MS pathogenesis is not well-established.
Purpose of the Study:
- To investigate the prevalence of gluten antibodies in patients with multiple sclerosis.
- To determine if elevated gluten antibodies warrant a gluten-free diet in MS management.
Main Methods:
- Plasma samples were collected from 36 patients diagnosed with MS.
- A haemagglutination technique was employed to quantify gluten antibody levels.
Main Results:
- Only one out of 36 patients exhibited detectable levels of gluten antibodies.
- The antibody level in the single positive case did not meet criteria to recommend a gluten-free diet.
Conclusions:
- The study found no significant evidence supporting the presence of gluten antibodies in the majority of MS patients.
- Current findings do not support the use of a gluten-free diet as a therapeutic strategy for multiple sclerosis management.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...